BTIG Reiterates Buy Rating on MiniMed Group (MMED)
Tweet Send to a Friend
BTIG analyst Marie Thibault reiterated a Buy rating and $25.00 price target on MiniMed Group (NASDAQ: MMED).The analyst comments "MiniMed ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


